Analyst Ratings for athenahealth (ATHN) [Neutrals]
ATHN Rating Summary
ATHN Price Target Summary
- Highest: $95.00 (Raymond James)
- Lowest: $50.00 (JPMorgan)
- Average: $72.75
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$72.75 (-16.1%)
Avg. $ Target:
$72.75 (-16.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/10/2012 | Sterne Agee | Upgrade | Neutral (Underperform) |
N/A (N/A) |
73.89 | 86.73 | 17.38% | Details |
| 10/1/2012 | Avondale Partners | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
91.77 | 86.73 | -5.49% | Details |
| 8/20/2012 | First Analysis | Downgrade | Equal Weight (Overweight) |
N/A (N/A) |
92.42 | 86.73 | -6.16% | Details |
| 5/3/2012 | Morgan Stanley | Upgrade | Equalweight (N/A) |
N/A (N/A) |
74.14 | 86.73 | 16.98% | Details |
| 12/16/2011 | Oppenheimer » Updated 2/8/2013 |
Upgrade | Perform (N/A) |
N/A (N/A) |
49.04 | 86.73 | 76.86% | Details |
| 9/30/2011 | Caris & Co. | Downgrade | Average (N/A) |
N/A (N/A) |
63.09 | 86.73 | 37.47% | Details |
| 8/5/2011 | Cowen | New Coverage | Neutral (N/A) |
N/A (N/A) |
54.17 | 86.73 | 60.11% | Details |
| 7/15/2011 | Goldman Sachs » Updated 5/2/2012 |
New Coverage | Neutral (N/A) |
63.00 (N/A) |
45.87 | 86.73 | 89.08% | Details |
| 12/17/2010 | Craig-Hallum | Downgrade | Neutral (N/A) |
N/A (N/A) |
39.76 | 86.73 | 118.13% | Details |
| 12/2/2010 | FBR Capital » Updated 5/2/2011 |
Downgrade | Market Perform (N/A) |
N/A (N/A) |
43.09 | 86.73 | 101.28% | Details |
| 10/1/2010 | Sidoti | Downgrade | Neutral (N/A) |
N/A (N/A) |
33.02 | 86.73 | 162.66% | Details |
| 8/17/2010 | Baird | Downgrade | Neutral (N/A) |
N/A (N/A) |
31.13 | 86.73 | 178.61% | Details |
